Cargando…
Reversible Valproate-Induced Subacute Encephalopathy Associated With a MT-ATP8 Variant in the Mitochondrial Genome
Introduction: There are several reported cases of patients developing motor and cognitive neurological impairment under treatment with valproic acid (VPA). We describe a woman who developed a subacute encephalopathy after VPA intake, harboring a mitochondrial DNA variant, previously described as cau...
Autores principales: | De Michele, Giovanna, Sorrentino, Pierpaolo, Nesti, Claudia, Rubegni, Anna, Ruggiero, Lucia, Peluso, Silvio, Antenora, Antonella, Quarantelli, Mario, Filla, Alessandro, De Michele, Giuseppe, Santorelli, Filippo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125373/ https://www.ncbi.nlm.nih.gov/pubmed/30214424 http://dx.doi.org/10.3389/fneur.2018.00728 |
Ejemplares similares
-
The Multiple Faces of Spinocerebellar Ataxia type 2
por: Antenora, Antonella, et al.
Publicado: (2017) -
A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design
por: Saccà, Francesco, et al.
Publicado: (2011) -
Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014) -
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
Antiphospholipid-Related Chorea
por: Peluso, Silvio, et al.
Publicado: (2012)